PPR-058 - Preliminary investigation and analysis of the awareness and implementation of risk management plans among pharmacists in Taiwan

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: PPR-058
• By: CHEN, ShuMi (Lotung Poh-ai Hospital, China Taiwan)
• Co-author(s): Dr ShuMi Chen (Lotung Poh-ai Hospital, Yilan, China Taiwan)
  Pharmacist Yifen Hsu (Lotung Poh-ai Hospital, Yilan, China Taiwan)
  
• Abstract:

  Introduction
  Ensuring medication safety is a global priority. Post-marketing safety concerns have led to regulatory actions, such as the withdrawal of Rofecoxib (Vioxx) due to its association with increased cardiovascular risk. To strengthen post-marketing surveillance, the European Medicines Agency (EMA) introduced the Risk Management Plan (RMP)..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login